Literature DB >> 952333

Abdominal pain of unknown etiology.

I J Sarfeh.   

Abstract

The influence of age, sex, duration of symptoms, and exploratory laparotomy on prognosis of adult patients with abdominal pain of unknown etiology was assessed in a retrospective review. Patients with incomplete diagnostic evaluation were excluded. Of the sixty-four patients studied, forty-six were female. Lack of improvement of symptoms in the follow-up period was 67% in females and 22% in males (p less than 0.05). Younger patients tended to have higher improvement rates. Of the patients whose duration of symptoms was less than fourteen days, 65% were improved and 25% were subsequently diagnosed, as compared with 14 and 9%, respectively, of those whose symptoms had been present for more than ninety days (p less than 0.05). Laparotomy did not influence rate of improvement and established a diagnosis in only one of twenty-three patients explored. It is concluded that few of these patients are likely to benefit from laparotomy, especially adult females whose symptoms have been present for more than three months.

Entities:  

Mesh:

Year:  1976        PMID: 952333     DOI: 10.1016/0002-9610(76)90283-x

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Anamnestic and psychological features in diagnosis and prognosis of functional abdominal complaints: a prospective study.

Authors:  G Bleijenberg; J F Fennis
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

2.  Psychiatric morbidity in patients with chronic abdominal pain.

Authors:  S S Kachhwaha; V S Chadda; A K Singhwal; P Bhardwaj
Journal:  Indian J Psychiatry       Date:  1994-10       Impact factor: 1.759

Review 3.  Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.

Authors:  James C Barton; J Clayborn Barton; Neha Patel; Gordon D McLaren
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.